M42, AstraZeneca, and SOPHiA GENETICS launch UAE broad liquid biopsy initiative to transform cancer diagnosis and care
M42, a global health leader powered by technology, continues to pioneer artificial…
AI-Driven Healthcare: Dr. Mujtaba Ali Khan Shares Burjeel’s Innovations
Dr. Mujtaba Ali Khan , CEO of Bourjeel Medical City and Group…
The Future of Leukemia Treatment: Dr. Faisal Khan on Biomarkers and Early Intervention | BMT
In this engaging episode, Dr. Faisal Masood Khan, Professor at the University…
A Step Toward Early Diagnosis
We have all heard the responses "Treatment," "No treatment," "There is treatment,"…
Ride with Rixos Movember Edition in Partnership with Friends of Cancer Patients
Abu Dhabi, UAE- November 2024- November is globally recognized as Men's Health…
MedxBay and Staque Unveil AI Doctors for Breast Cancer and Mental Health Awareness at GITEX
MedxBay, a leading global healthcare platform, has partnered with Staque, an industry…
‘‘We Are Shifting From A Reactive To Preventive Approach In Healthcare’’ – Pelin Incesu
AstraZeneca is making a significant impact in the Middle East and Africa…
Imfinzi Approved in the US for Resectable Lung Cancer Treatment
The US has approved AstraZeneca's Imfinzi (durvalumab) combined with chemotherapy to treat…
BD and Quest Diagnostics Collaborate on Cancer and Disease Diagnostics
July 25, 2024- BD and Quest Diagnostics announced a global collaboration agreement…
Can This New Treatment Extend the Lives of Leukemia Patients?
Rochester- July 2024- In a new multicenter international study led by the…